semiconductor / news / / CNBC
Health Canada approved the first one by Indian drugmaker Dr. Reddy's Laboratories on April 28.
Health Canada has approved two generic versions of Ozempic, from Dr. Reddy's and Apotex.
KEY POINTS
- Seven additional generic Ozempic applications are currently under review by Health Canada.
- Canadian law mandates a 65% price cut for Novo's Ozempic once three generics are available.
- Novo anticipates only a low single-digit impact from these generics, relying on its savings card.
COMPANIES
Summarized by Newsio from CNBC. How we summarize →